Tested Applications
| Positive WB detected in | Jurkat cells, HeLa cells |
| Positive IP detected in | HEK-293 cells |
| Positive IHC detected in | human pancreas cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | A431 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:1000-1:4000 |
| Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| Immunohistochemistry (IHC) | IHC : 1:20-1:200 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
11675-1-AP targets SUGT1 in WB, IHC, IF/ICC, IP, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag2275 Product name: Recombinant human SUGT1 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-333 aa of BC000911 Sequence: MAAAAAGTATSQRFFQSFSDALIDEDPQAALEELTKALEQKPDDAQYYCQRAYCHILLGNYCVAVADAKKSLELNPNNSTAMLRKGICEYHEKNYAAALETFTEGQKLDSADANFSVWIKRCQEAQNGSESEVWTHQSKIKYDWYQTESQVVITLMIKNVQKNDVNVEFSEKELSALVKLPSGEDYNLKLELLHPIIPEQSTFKVLSTKIEIKLKKPEAVRWEKLEGQGDVPTPKQFVADVKNLYPSSSPYTRNWDKLVGEIKEEEKNEKLEGDAALNRLFQQIYSDGSDEVKRAMNKSFMESGGTVLSTNWSDVGKRKVEINPPDDMEWKKY Predict reactive species |
| Full Name | SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae) |
| Calculated Molecular Weight | 41 kDa |
| Observed Molecular Weight | 35-41 kDa |
| GenBank Accession Number | BC000911 |
| Gene Symbol | SUGT1 |
| Gene ID (NCBI) | 10910 |
| RRID | AB_2197436 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9Y2Z0 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for SUGT1 antibody 11675-1-AP | Download protocol |
| IHC protocol for SUGT1 antibody 11675-1-AP | Download protocol |
| IP protocol for SUGT1 antibody 11675-1-AP | Download protocol |
| WB protocol for SUGT1 antibody 11675-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The SUGT1 Polyclonal antibody (11675-1-AP) is cited in 10 publications across journals including British Journal of Pharmacology, International Journal of Oncology, Frontiers in Immunology, JCI Insight, Oncogenesis, Journal of Ovarian Research, Translational Oncology, European Journal of Medical Research, and PLoS One. Research fields cover NLRP3 inflammasome-driven diseases, sepsis-induced acute lung injury, colorectal, ovarian and serous ovarian cancers, SUGT1 oncogenic roles, Hsp90 chaperone biology, and recurrent pregnancy loss with antiphospholipid syndrome. Applications include WB, IHC, and IP across human and mouse samples.
| Species | Application | Title |
|---|---|---|
Br J Pharmacol Notoginsenoside-Fa mitigates vascular endothelial permeability via targeting SUGT1 to stabilize NLRP3 in a resting state.
| ||
Int J Oncol Overexpression of SUGT1 in human colorectal cancer and its clinicopathological significance. | ||
Front Immunol HSF1 Protects Sepsis-Induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome Activation. | ||
JCI Insight Echinatin effectively protects against NLRP3 inflammasome-driven diseases by targeting HSP90. | ||
J Ovarian Res Mechanism by which SUGT1 downregulates FH to promote proliferation and migration in serous ovarian cancer |











